Compare NSPR & COHN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NSPR | COHN |
|---|---|---|
| Founded | 2005 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.7M | 32.9M |
| IPO Year | 2009 | 2003 |
| Metric | NSPR | COHN |
|---|---|---|
| Price | $0.72 | $13.95 |
| Analyst Decision | Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 85.7K | 15.6K |
| Earning Date | 05-04-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 4.35% |
| EPS Growth | N/A | ★ 5537.50 |
| EPS | N/A | ★ 0.42 |
| Revenue | $2,310,000.00 | ★ $275,564,000.00 |
| Revenue This Year | $57.98 | N/A |
| Revenue Next Year | $95.41 | N/A |
| P/E Ratio | ★ N/A | $33.31 |
| Revenue Growth | N/A | ★ 246.19 |
| 52 Week Low | $0.63 | $9.19 |
| 52 Week High | $2.93 | $32.60 |
| Indicator | NSPR | COHN |
|---|---|---|
| Relative Strength Index (RSI) | 39.07 | 57.48 |
| Support Level | $0.69 | $12.84 |
| Resistance Level | $1.04 | $14.50 |
| Average True Range (ATR) | 0.03 | 0.60 |
| MACD | 0.01 | 0.13 |
| Stochastic Oscillator | 71.29 | 67.39 |
InspireMD Inc is a United States-based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System. It generates the majority of the revenue from the sales of CGuard EPS, which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The Company has one operating and reporting segment that develops, manufactures, and markets products for the treatment of carotid artery disease and other vascular diseases, including the Company's proprietary CGuard stent platform.
Cohen & Co Inc is a United States company that delivers financial services in fixed-income markets. It is focused on small-cap banking institutions and has grown to provide an expanding range of capital markets and asset management services. It has three business segments. The Capital Markets segment, which is the key revenue driver, consists of fixed-income sales, trading, matched book repo financing, new issue placements in corporate and securitized products, and advisory services. The Asset Management segment manages assets within collateralized debt obligations, managed accounts, joint ventures, and investment funds. The Principal Investing segment is comprised of investments to earn return rather than to support trading, matched book repo, or other Capital Markets segment activities.